RUSSELL R HORN

Allopathic & Osteopathic Physicians|Family Medicine VALLEY CENTER, KS NPI 1528062148

General Payments — all program years on this page

$3,396.74

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 212
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $688.05 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $688.0538

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $150.7110
Novo Nordisk AS $143.378
Abbott Laboratories $79.614
E.R. Squibb & Sons, L.L.C. $74.442
ABBVIE INC. $49.133
Amgen Inc. $47.943
GlaxoSmithKline, LLC. $42.442
Janssen Pharmaceuticals, Inc $35.882
Lilly USA, LLC $30.312
SANOFI-AVENTIS U.S. LLC $19.911
PFIZER INC. $14.311

By program year

Program yearAmountRecords
2018 $300.4016
2019 $264.0720
2020 $745.3751
2021 $650.3140
2022 $748.5447
2023 $688.0538

Records — PY2023 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1001678527 Novo Nordisk Inc $11.28 08/30/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001678537 Novo Nordisk Inc $16.02 05/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001678547 Novo Nordisk Inc $16.17 08/30/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001678557 Novo Nordisk Inc $16.61 01/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001678567 Novo Nordisk Inc $16.69 02/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001678577 Novo Nordisk Inc $17.46 03/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001678585 Novo Nordisk Inc $24.50 07/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001678595 Novo Nordisk Inc $24.64 12/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003448293 GlaxoSmithKline, LLC. $18.90 10/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003448495 GlaxoSmithKline, LLC. $23.54 06/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011445265 AstraZeneca Pharmaceuticals LP $16.07 05/04/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011497971 AstraZeneca Pharmaceuticals LP $16.40 07/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011734231 AstraZeneca Pharmaceuticals LP $14.12 01/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011896277 AstraZeneca Pharmaceuticals LP $13.18 05/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011914605 AstraZeneca Pharmaceuticals LP $16.21 08/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1012030223 AstraZeneca Pharmaceuticals LP $18.14 03/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015354898 AstraZeneca Pharmaceuticals LP $15.05 12/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015423853 AstraZeneca Pharmaceuticals LP $14.02 04/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015646989 E.R. Squibb & Sons, L.L.C. $59.34 07/18/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015647027 E.R. Squibb & Sons, L.L.C. $15.10 09/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015746689 AstraZeneca Pharmaceuticals LP $13.83 08/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015908671 AstraZeneca Pharmaceuticals LP $13.69 02/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1018489109 Abbott Laboratories $17.74 06/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1018496289 Abbott Laboratories $23.87 03/15/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1018498451 Abbott Laboratories $18.99 05/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1018513625 Abbott Laboratories $19.01 10/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1020099785 Amgen Inc. $13.03 01/16/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1020099789 Amgen Inc. $19.96 04/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1020099793 Amgen Inc. $14.95 08/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1032172089 Lilly USA, LLC $16.88 08/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1032380387 Lilly USA, LLC $13.43 02/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049643528 SANOFI-AVENTIS U.S. LLC $19.91 03/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1050563247 PFIZER INC. $14.31 05/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
987854011 Janssen Pharmaceuticals, Inc $17.47 07/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
987854019 Janssen Pharmaceuticals, Inc $18.41 09/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
997501253 ABBVIE INC. $18.85 03/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
997501255 ABBVIE INC. $15.37 04/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
997501257 ABBVIE INC. $14.91 09/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.